Mohamed Abdel‐Aziz

Author

Mohamed Abdel‐Aziz

Also Known As

Abdel-Aziz, Mohamed, MOHAMED ABDEL-AZIZ, Mohamed Abdel-Aziz, Mohamed Abdelaziz, Mohamed Abdel‐Aziz, Mohamed S. Abdel‐Aziz

129

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Minia University Assiut University Jouf University Deraya University Al-Azhar University

About

Mohamed Abdel‐Aziz is an author at Minia University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	45	2.6K
2	Natural Sciences	21	29	1.2K
3	Biochemistry	15	20	674
4	Engineering	1	1	12
5	Health Sciences	1	1	23

Mohamed Abdel‐Aziz

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities Mohamed Abdel‐Aziz, Gamal El‐Din A. Abuo‐Rahma, Alaa A. Hassan European Journal of Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)Novel Pyrazole DerivativesMedicinePsychotropic Medication	2009	399
Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors Hany A.M. El-Sherief, Bahaa G. M. Youssif, Syed Nasir Abbas Bukhari, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineRational Drug Design1,2,4-Triazole DerivativesEgfr Inhibitors	2018	176
Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies Hany A.M. El-Sherief, Bahaa G. M. Youssif, Syed Nasir Abbas Bukhari, Bioorganic Chemistry Combinatorial ChemistryMedicinal ChemistryMedicineNatural SciencesPharmacology	2017	171
EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules Hesham A. Abou‐Zied, Bahaa G. M. Youssif, Mamdouh F. A. Mohamed, Bioorganic Chemistry Medicinal ChemistryMedicineNovel Xanthine DerivativesEgfr InhibitorsChalcone Moiety	2019	137
Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity Mohamed Abdel‐Aziz, Soeun Park, Gamal El‐Din A. Abuo‐Rahma, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryNatural SciencesMedicineIi Inhibitory Activity	2013	122
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, Bioorganic Chemistry Combinatorial ChemistryMedicinal ChemistryPotent Antiproliferative AgentMedicineBrafv600e Kinases	2020	111
Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents Mohamed Hisham, Bahaa G. M. Youssif, Essam Eldin A. Osman, European Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceMedicineNovel Xanthine DerivativesPharmacological Agent	2019	88
New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells Fatma F. Ahmed, Amer Ali Abd El‐Hafeez, Samar H. Abbas, European Journal of Medicinal Chemistry New 1,2,4-Triazole-chalconeMedicineApoptosisPharmacologyCell Death	2018	87
Design, synthesis, mechanistic studies and in silico ADME predictions of benzimidazole derivatives as novel antifungal agents Martha M. Morcoss, Elshimaa M. N. Abdelhafez, Reham Ali Ibrahem, Bioorganic Chemistry Medicinal ChemistryAntifungal AgentMechanistic StudiesBenzimidazole DerivativesAntifungal Agents	2020	86
1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities Marwa Ali A. Fathi, Amer Ali Abd El‐Hafeez, Dalia Abdelhamid, Bioorganic Chemistry Leukemia Cell GrowthMedicinal ChemistryStat3 ActivitiesMedicine1,3,4-Oxadiazole/chalcone Hybrids	2018	76

Page 1